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Field, Rickard, and Hutt  (1, 2) have reported the occurrence of a  sex-llnked 
hemorrhagic  disease in  male  dogs  similar to  hemophilia in  man.  The  chief 
symptoms were due to subcutaneous hematomas and hemarthroses.  Deform- 
ities frequently occurred.  Most of the pups affected with the disease died dur- 
ing the first 12 weeks of life.  Of 17 affected males described, none were reared 
to maturity.  The female stock, heterozygous for the disease, was turned over 
to this laboratory so that  a  controlled breeding program could be instituted, 
and a  more extensive investigation of the clotting defect could be made.  Our 
studies of the affected male progeny indicate that the clotting defect is identical 
with  that  found  in  human  hemophilia.  Repeated  transfusions  with  whole 
blood or plasma alleviate the hemorrhagic phenomena,  and permit growth of 
affected dogs  to  maturity practically free of deformities. 
Materials and Methods 
The male bleeder dogs used in this study were born and reared in our kennel  The dams 
were known  transmitters of the disease and of Irish setter stock.  The sires were  normal 
males selected without respect to breed. 
The clotting time of whole blood was determined by two methods: (a) a modified Lee and 
White method (3), in which two 10 X  75 ram. dry glass tubes were used for each test, and 
(b) the silicone method, in which needles, syringes, and tubes coated with methylchlorsilane 
(4) were used.  The method for determining the clotting time of platelet-rich and platelet- 
poor citrated plasmas has been described (5).  Platelet-rich  plasmas were obtained by centri- 
fugation of citrated whole blood for 5 minutes at 450 g.  Platelet-poor plasmas were prepared 
by centrifugation for 2 hours at 13,000 g in silicone-treated glassware. 
Bleeding time was determined by a modification of Duke's method (6).  The site of incision 
in one series of observations was the mucous membrane of the lip (1); in another series the 
inner hairless aspect of the pinna (tragus of the ear) was used.  Incisions were approximately 
2 ram. deep.  On the lip the incisions were 2 to 5 mm. long, on the ear 5 to 7 mm. 
The platelets in whole blood were counted by a  modification  of Nygaard's method (7), 
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using 3.2 per cent sodium citrate as a diluent in the ratio of 4 parts to one part of whole blood. 
After 30 minutes of sedimentation s plasma was transferred  to a  counting chamber and the 
platelets were counted directly. 
Fibrinogen was determined by the method of Jones and Smith (8). 
Serum calcium was determined by the method of Kramer and Tisdall (9). 
Prothrombin was determined by the two-stage method of Warner, Brinkhous, and Smith 
(10,  11).  Fresh dog serum,  as described in the original method, was used for plasma de- 
fibrination (10).  The plasma prothrombin time was determined by the method of Quick (12). 
For determination of thrombin clotting time, 0.4 ml. of eitrated plasma was mixed with 
0.1 ml. thrombin, prepared by dissolving Parke-Davis topical thrombin in 0.9 per cent NaC1. 
Thrombin solutions of two different strengths were used: one was diluted to give a 15 second 
clotting time with normal citrated plasma in this test; the other was diluted to give a  45 
second  clotting time. 
The qualitative method of Conley~ Rathbun, Morse, and Robinson (13) for demonstrating 
anticoagulants in plasma was used.  The clotting tests were carried out at 28°C.  Quantita- 
five determination  of plasma  antithrombin  was made by the method  of Wilson  (14). 
For transfusions, citrated whole blood and plasmas were used.  Unless otherwise indicated 
the whole blood was freshly prepared.  The citrated plasma was stored in 40 mi. aliquots at 
--35°C. and used within 10 days of collection. 
Course of the Malady and the Effect of Transfusions 
The observations given below were made on bleeder dogs from nine separate 
litters.  Nine of the bleeder animals  were reared to maturity. 
The Hemorrhagic Phenomena.--These dogs  suffered  from repeated  hemor- 
rhages which were occasionally massive and fatal.  The  hemorrhages usually 
appeared spontaneously, although at times observable trauma was the cause. 
Hemorrhages involved many tissues.  The most common sites were the joints, 
particularly the hip and shoulder joints.  The hemarthroses appeared painful. 
The  joints were swollen  and  were held immobile in a  flexed  position.  The 
animals refused to bear weight on an affected extremity, and they resisted pas- 
sive movements of the joints.  If promptly treated with transfusions, the~swell- 
ings usually disappeared in 2 to 4 days, and return of function appeared com- 
plete.  Involvement of a joint appears to predispose it to further hemorrhage. 
Ill a  few dogs deformity with limitation  of motion occurred in joints which 
were the  site  of frequent  hemorrhage.  Two  dogs have  developed seapulo- 
humeral ankyloses.  Subcutaneous hemorrhages were the second most common 
type.  They have been observed more often in pups than in adult dogs.  Sev- 
eral young animals  have had hematomas of the scalps resembling the cephal- 
hematoma  of infants.  Large  spreading  hematomas,  occasionally reaching  a 
very large  size,  have been observed.  Another  site of hemorrhage  has been 
the gums, particularly during tooth eruption.  Internal hemorrhages have been 
observed less frequently.  One adult dog has had signs of cerebral hemorrhage, 
followed by paraplegia.  A litter mate developed a hemothorax.  Another dog 
had signs of massive intestinal bleeding. 
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different animals.  Some bleeder animals have suffered from frequent and se- 
vere hemorrhagic episodes.  In these dogs, prolonged periods of disability have 
resulted, despite repeated transfusions.  In contrast, other dogs have developed 
hemorrhages less frequently,  and with prompt administration  of transfusions 
no deformities have resulted.  The varied course is illustrated by case histories 
of two dogs, one a severe bleeder  and  the other a  comparatively mild bleeder 
(see below). 
Effect  of Blood or Plasma  Transfusions  on the Hemorrhagic Phenomena and 
Survival Time.--Transfusions promptly alleviated the hemorrhagic phenomena. 
For  severe  hemorrhages  in  which  the  animal  showed  evidence  of anemia  or 
shock, repeated whole blood transfusions have been given.  For the more fre- 
quent  but  less  severe  hemorrhages,  transfusions  with  normal  citrated  dog 
TABLE I 
The Effect of Transfusions on Longevity of the Bleeder Dogs 
No. of bleeder dogs 
Group  I  Survival time, mos. 
Treated .............................  11  2"  1"  0  0 
Untreated ...........................  10  8~:  1:~  0  1§ 
Over 12 
8 
0 
* Death not associated with hemorrhage; one pup, aged 2 months, died of unknown cause, 
no hemorrhage at autopsy; one pup, aged 2 months,  died of intussusception;  one pup aged 
4 months died of distemper. 
Death following extensive hemorrhage. 
§ No treatment until  10 months of age, when plasma transfusions were started. 
plasma have been used in the amount of 2.5 to 5 ml. per kilo, given on alternate 
days as long as symptoms last.  The efficacy of the transfusions is shown by 
the prompt improvement of treated animals.  If the hemorrhage is external, ces- 
sation of bleeding is usually observed within 5 to 10 minutes after transfusion. 
Dogs treated  promptly for each hemorrhagic episode have reached maturity, 
while untreated dogs have usually died early in life.  This is shown in Table I. 
It will be noted that 90 per cent of untreated  animals died of hemorrhage in 
the first 6 months of life, while none of the treated animals died from this cause 
during the  1st year of life. 
Case Abstract of a Severe Hemophiliac.--Dog  4, a  male, was  born on Apr.  2,  1947, the 
first of a litter of five males.  The birth weight was 377 gin.  The umbilical cord was ligated 
because of continued oozing of blood from the stump.  Artificial feeding with a cow's milk 
formula was started on the 1st day of life.  The formula was supplemented with cereals during 
the 3rd week of life, and homogenized vegetables were added during the period of tooth erup- 
tion.  From the age of 8 weeks, dry commercial dog food has been given.  Ground and biscuit I00  CANINE HF~OPH~A 
types of food have been alternated,  supplemented by brewer's yeast, wheat germ, and vita- 
mins A and D.  Maximum weight, 21.8 kilos, was attained at  14 months.  One-quarter 
growth in terms of weight was reached at 2½ months, one-half growth at 4 months, and three- 
quarters growth at 6 months.  Dietary intake and weight have always been less than those 
of the litter mates.  The animal has been kept in an individual cage, but allowed to exercise 
daily on a runway.  Distemper vaccination and treatment with a vermifuge, n-butyl chloride, 
were given first at 3 months of age, and repeated every 6 months thereafter. 
Lameness has characterized this dog from puppyhood.  The first symptom was on the 
17th day of life, when the left front leg became lame.  Frequent severe hemarthroses have 
recurred in many joints.  During the 9th month of life the animal was almost bedridden 
and had to be helped to his feet.  Subsequently he improved, only to have the severe joint 
symptoms recur during the 15th month of life.  In the 16th month, ankylosis of the right 
shoulder joint was noted roentgenologically. 
Except following transfusions, the clotting time has always been prolonged.  Usually it 
has been between 60 and 120 minutes.  However a blood sample obtained on the 18th day 
of life was unclotted after 4 hours, but did clot overnight.  The dog  has received 118 trans- 
fusions in 22 months.  Approximately 4 liters of plasma and 250 ml. of whole blood have 
been given. 
At the age of 22 months, the dog is greatly crippled and his general activity is limited.  He 
is able to arise and walk, but cannot run.  Muscular atrophy is pronounced.  He shows no 
signs of sexual maturity; he fails to elevate his leg during urination and has no interest in 
females in rut.  His appearance is that of an emaciated arthritic  old dog. 
Case Abstraa of a Mild Hemoptriliac.--Dog 6, a male, and a litter mate of dog 4, was 
born Apr. 3, 1947.  The birth weight was 472 gin.  He has been reared in a manner prac- 
ticaily identical with that of his sibling described above.  From the first week of life, this 
dog was more vigorous and had a  greater  appetite  than his siblings.  Maximum weight, 
26.5 kilos, was reached at 16½ months.  One-quarter growth was reached at 2½ months, half- 
growth at 4½ months, and three-quarters growth at 7½ months.  Except following transfu- 
sions, clotting times have usually ranged between 28 and 50 minutes. 
Many episodes of lameness have occurred, but they were less frequent and of shorter dura- 
tion than those of his hemophllic brother.  The cervical spine and left hind leg have been 
affected most often.  Ninety transfusions, totaling 2.8 liters of plasma and 200 ml. of whole 
blood have been given.  Many of these transfusions have been given to minimize the pos- 
sibility of hemorrhage incident to the rough sex play of mating.  At the age of 22 months, 
he is the largest, most aggressive male in the kennel.  Except during short, infrequent periods 
of lameness and one episode of massive intrathoraeic hemorrhage, superficially  he has appeared 
to be completely normal. 
EXPERIMENTAL  OBSERVATIONS 
The Clotting Anomaly 
Prolonged Clotting  Time.--The  clotting times were prolonged in all bleeder 
animals.  One set of determinations is given in Table II.  In plain glass tubes, 
the clotting times of individual dogs varied from day to day.  Practically all 
clotting time determinations fell within the range of 40 to 120 minutes.  Once 
clotting occurred  clot retraction was  as  great  in the  hemophilic blood as  in 
normal whole blood.  In silicone-treated glassware,  the whole blood clotting 
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time of recalcified plasma rich in platelets was much shorter than the whole 
blood clotting time, while the recalcified platelet-poor plasma did not clot in 
the  24 hours of observation.  Similar findings have been obtained in human 
hemophilia. 
Bleeding Time Normal or Prolonged, Depending on Site and Size of Incision.- 
Bleeding from small incisions of the mucous membrane of the lip stopped in 
the same time as in normal animals  (Table III).  In contrast,  bleeding from 
slightly larger incisions of the ear was profuse, and continued for many hours 
TABLE II 
The Clotting Times  of Whole Blood and Plasma of Bleeder Dogs, Female Transmitter Dogs, 
and Normal Dogs 
Dog No.  Sex 
1  M 
2  M 
3  M 
4  M 
5  M 
6  M 
7  M 
8  M 
9  F 
10  F 
11  F 
12  M 
Type 
Hemophilic 
Hemophilic 
Hemophilic 
Hemophilic 
Hemophilic 
Hemophilic 
Hemophilic 
HemophiHc 
Transmitter 
Transmitter 
Normal 
Normal 
Clotting time* 
Recalcified citrated plasma 
Platelet-rich 
plasma~t 
Whole blood 
Lee-White  Silicone 
rain.  rain. 
43  1200 
66  1200 
54  1320 
71  1380 
65  1680 
43  1200 
73  540 
82  1140 
5  37 
8  42 
6  28 
7½  40 
rain. 
17 
14 
14 
15 
28 
12 
18 
15 
2 
2 
2 
2 
Platelet-poor 
plasma_~_~ 
rain. 
I  >1440 
>1440 
>1440 
>1440 
>1440 
>1440 
>1440 
17 
14 
19 
16 
* All clotting times except in the column labeled silicone were done in 
Platelets per c.mm. of plasma, 125,000 to 200,000. 
§ Platelets per c.mm. of plasma, less than 300. 
ordinary glassware. 
unless controlled by transfusions or local application of thrombin.  The bleed- 
hag times of normal dogs from ear incisions were 2½ to 3 minutes.  The results 
of the bleeding time test in four bleeder dogs are given.  In one animal (dog 7) 
bleeding  stopped in  3  minutes,  but  oozing  from under  the  edge of the clot 
developed a few minutes later and continued for 24 hours.  In another animal 
(dog 6) temporary stoppage of bleeding occurred in 4 minutes, but oozing con- 
tinued,  and bleeding was again profuse at the end of 2 hours.  Bleeding was 
controlled by the local application of thrombin and by a transfusion of 40 ml. of 
citrated normal dog plasma.  In two other animals (dogs 4 and 8) bleeding was 
continuous  and profuse for 15  to 20 minutes.  Blood loss was at the rate of 102  CANINE  HEMOPHILIA 
1.5  to 2.0 ml. per minute.  Hemostasis was accomplished by the application 
of thrombin and normal plasma transfusions. 
Study of Various Clotting  Factors.--Blood platelet counts, plasma fibrinogen 
levels, serum calcium values, and plasma prothrombin determinations were all 
within  the range of normal  (Table III).  No difference was observed in  the 
thrombin clotting times of plasma from bleeder and normal dogs (Table III). 
This would indicate that the fibrinogen reactivity was normal, and that anti- 
thrombic activity was not excessive.  No excess of anticoagulants was demon- 
strable.  In one group of experiments, native plasma from three bleeder dogs 
TABLE III 
Clotting Factors and Clotting Tests in Bleeder Dogs, Transmitter Female Dogs, and Normal 
Dogs 
Dog 
No. 
1 
2 
3 
4 
6 
7 
8 
9 
10 
11 
12 
13 
Sex  Type 
M  [  Hemophilic 
M  Hemophilic 
M  Hemophilic 
M  Hemophilic 
M  Hemophilic 
M  Hemophilic 
M  Hemophilic 
F  I  Transmitter 
F  Transmitter 
F  Normal 
M  Normal 
M  1  Normal 
Bleed- 
ing 
time 
~ucou 
mem- 
)rane) 
$8C. 
95 
145 
6O 
110 
8O 
115 
135 
110 
7O 
85 
110 
105 
Thrombln clot- 
[  Plash  tLng  time 
Plasm  Serum  t  ~rr°~  Pro- 
rag.~  hrom-  With  Platelets  fibrin  calci-  bin  bin  With 
concen-  dilute  ogen  um  (two  time  trat2d throm- 
stage  throm-  bin 
bin 
7o.lc.mm.  mg.I  per  J I00 rtt]  I00 ml.  cen~  se¢.  sec.  sec. 
295,000  327  10.0  95  9.0  --  -- 
294,000  451  11.2  95  9.5  17  45 
271,000  626  10.3  90  9.0  15  44 
225,000  333  10.8  104  9.0  --  -- 
288,000  427  9.8  109  10.0  17  47 
102,000  406  10.9  96  9.5  15  46 
325,000  387  9.7  91  9.0  --  -- 
304,000  350  9.7  106  9.8  14  41 
253,000  331  9.5  .... 
~19,000  252  11.0  96  9.3  I  15  44 
280,000  467  11.2  106  10.0  16  46 
i00  9.5  ,  15  45  350,000  [  360  10.2 [  I 
was mixed with freshly drawn normal dog blood  (13)  and the clotting times 
determined.  In all tubes,  the  clotting times were within  the  same range as 
the normal controls (5 to 7 minutes).  Determinations of plasma antithrombin 
(14)  in four bleeder dogs gave results of 90 to 120 per cent of normal control 
dogs; this is within the range of normal. 
Recent evidence indicates that faulty conversion of prothrombin to thrombin 
may be due to a deficiency of one or more cofactors which accelerate prothrom- 
bin conversion in the presence of optimal calcium and an excess of thrombo- 
plastin.  This subject has been summarized recently by Seegers and Ware (15). 
A number of terms, as prothrombin convertibility factor, Ac globulin, factor V, 
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bin conversion.  Several qualitative tests were done to determine whether such 
a factor was lacking in the bleeder dogs.  In one series of experiments it was 
shown  that  with  optimal  Ca  +~  concentration  and  excess  thromboplastin, 
thrombin formed at the same rate in bleeder and normal dog plasma.  The 
results  of one  experiment are  given  in  Table  IV.  In  another  experiment, 
plasma Ac globulin was added to whole hemophilic blood to determine whether 
it would correct the clotting defect.  Bleeder dogs 4 and 7 were used.  Clotting 
times are  given in  Table II.  Purified bovine plasma  Ac  globulin  (16)  was 
added  to normal and bleeder whole blood so  that  its final concentration in 
each was equivalent to 17 rag. per 100 ml. of plasma.  No effect on clotting 
was noted.  The results of the prothrombin tests (Table III) likewise indicate 
that prothrombin was converted to thrombin at a  normal rate; if a  factor V 
TABLE IV 
Rate of Thrombin Formation in Normal and Bleeder Dog Plasma with Optimal Recalcification 
and Excess Thromboplastin 
Clotting time, $ec. 
Diluted plasma*  Prothrombin conversion tlrne~ 
sec--  sec--  sec--  sec____~..  I  sec___~_,  sec.___~.,  sec. 
Normal  .............................  20  17  I  16  16  16 
Hemophilic  ..........................  [  21  ]  18  i  i  16  [  16  ]  16  /  16 
* Plasma was diluted so that after optimal recalcifieation  and addition of thromboplastin, 
thrombin concentration in the clotting mixtures would be approximately 1 unit. 
:~ Period of reaction of mixtures of plasma, Ca  ++, and thromboplastin prior to the ad- 
dition of fibrinogen. 
deficiency existed, the plasma prothrombin time should have been prolonged 
(17), even if the prothrombin was normal in the two-stage test. 
Impaired  Prolhrombin  Utilization;  Correction  by  Tkromboplastin,  Normal 
Plasma, or Fraction/.--During and after clotting of normal whole blood, the 
prothrombin rapidly disappears.  Within  2 hours after collecting the blood, 
little prothrombin remains.  In hemophilia, on the other hand, prothrombin 
utilization is delayed, and relatively large amounts of prothrombin remain in 
the serum hours and even days after clotting occurs.  Periodic determination 
of the residual prothrombin in serum gives a measure of the rate of conversion 
of prothrombin to thrombin and provides a delicate test of the course of clotting. 
This procedure (18), devised 10 years ago, is a sensitive indicator of the hemo- 
philic state, and of changes resulting from the use of corrective agents.  This 
technique  was  used  to  foUow  the  rate  of prothrombin  conversion in  blood 
samples obtained from bleeder dogs (Table V, tests 1 to 3).  It will be observed 
that very little prothrombin was consumed in 4  hours.  Thereafter the pro- 104  CANINE HEMOPHILIA 
TABLE V 
Delayed Prothrombln Utilization Cn Hemophilic Blood; Corrective Effect of Thromboplastin, 
Normal Plasma, and Fraction I 
Test 
No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
Blood 
Hemophilic 
Hemophilic 
Hemophilic 
Normal 
Normal 
Normal 
Hemophilic 
Hemophilic 
Hemophilic 
Hemophilic 
Hemophilic 
Hemophilic 
Hemophilic 
Hemophilic 
Hemophilic 
Hemophilic 
Hemophilic 
Hemophilic 
Hemophi!ic 
Hemophilic 
None 
None 
None 
None 
None 
None 
Thrombo- 
plastin:~ 
Thrombo- 
plastin~ 
Thrombo- 
plastin~: 
Thrombo- 
plastin~ 
Thrombo- 
plastin~ 
Normal  dog 
plasma 
Normal  dog 
plasma 
Normal  dog 
Material added 
Amount per 
Type  100 rid. 
whole blood 
ml. 
0.1 
0.01 
0.001 
0.00001 
0.000001 
10.0 
1.0 
0.1 
plasma 
Normal  dog  0.01 
plasma 
Normal  dog  0.001 
plasma 
Normal  dog  0.0001 
plasma 
Normal  dog  0.00001 
plasma 
Fraction  I  10.0 
(human)  (0.3 gm.) 
Fraction  I  10.0 
(bovine)  (0.3  gm.) 
Residual prothrombin content* 
(per cent of original plasma) 
Time after collection  of blood 
15  30  60  4  24  [  48 
min.  rain.  rain.  hrs.  hrs.  i  hrs. 
i 
100  --  96  69  22 
100  --  96  61  27 
100  --  96  57  20 
59  30  <10  <10  <10 
48  16  <10  <10  <10 
46  30  <10  <10  <10 
<10  <10  <10  <10  <10 
76  59  <10  <10  <10 
100  85  44  31  16 
100  100  54  22  22 
100  100  100  54  24 
18  <10  <10  <10  <10 
22  <10  <10  <10  <10 
62  42  <10  <10  <10 
74  62  18  <10  <10 
911  91  --  20  19 
100 I  93  65  23  '  20 
100l  100  68  23  23 
78  43  <10  <10  <10 
71  27  <10  <10!  <10 
* At the intervals indicated,  the samples were mixed with approximately  one-seventh their 
volume of 1.85 per cent potassium  oxalate,  centrifugalized  at 2800 g for 15 rain.,  and  the 
residual prothrombin  determined by the two-stage test. 
Thromboplastic  lung extract (11); other extracts,  similarly prepared:  contained  3.3 gin. 
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thrombin slowly  disappeared.  Serum  obtained 48  hours after clotting still 
contained approximately the same amount of prothrombin as did normal serum 
obtained 30 minutes after clotting. 
The delayed utilization of prothrombin in the blood  of these animals can 
be corrected in vitro by the addition of small amounts of thromboplastin, normal 
dog plasma, or a protein fraction (fraction I) prepared from either bovine or 
human plasma (Table V, tests 7 to 20).  Addition of a small amount of throm- 
boplastic lung extract (equivalent to 0.01 ml. per 100 ml. hemophilic blood) 
accelerated prothrombin utilization to a nearly normal rate.  From data given 
in the table, it can be calculated that 0.33 mg. of solids was contained in this 
amount of thromboplastin added to 100 ml. of whole hemophilic blood.  This 
is  close to  the amount of thromboplastin previously found necessary  for a 
normal clotting rate in human hemophilia (18).  In these experiments, a notice- 
able effect was observed  with as little as 0.001 ml. of thromboplastic extract 
per 100 ml. of whole blood. 
Addition of normal plasma in amounts of 1 to 10 ml. per 100 ml. of whole 
hemophilic blood greatly accelerated  the prothrombin consumption.  Addition 
of only 0.01 ml. of normal plasma per  100  ml. of hemophilic  blood  had an 
appreciable effect, but with lesser amounts of plasma, changes from the control 
values were  slight. 
Both human and bovine fraction I were effective in accelerating prothrombin 
consumption.  However, their corrective action appears to be considerably less 
than that of equivalent amounts of normal plasma.  Part of this difference 
may be due to species specificity of the antihemophilic  factor. 
The Formed Elements and the Corrective Action of Normal Plasma.--As shown 
above,  the clotting defect of whole blood  was  corrected  by the addition of 
normal plasma.  However, the corrective action of plasma was dependent upon 
the presence of platelets and perhaps other formed elements  (Table  VI).  It 
will be noted in the table that whole hemophilic blood quickly clotted in the 
presence  of normal blood or plasma, and that its prothrombin promptly dis- 
appeared (tests 1 to 3).  When the number of platelets in the mixtures was 
reduced (tests 4 to 5), clotting was accelerated  but the acceleration  was con- 
siderably less  than that observed  in mixtures having a  full complement  of 
formed elements.  In  the  absence  of formed elements  (test 6),  the normal 
plasma failed to induce clotting in the course of the experiment.  Yet  this 
same plasma was highly effective when mixed with whole blood.  These data 
would indicate that a factor in normal plasma interacts with the formed ele- 
ments, particularly platelets, to initiate clotting, and that this factor is deficient 
in the bleeder dog plasma.  Also, if an adequate number of platelets are not 
present, the full effectiveness of the antihemophilic principle does not manifest 
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Effect of Transfusions  on the Clotting Anomaly 
Various  blood  and  plasma preparations  were  transfused  into  the  bleeder 
animals in a series of twenty-six experiments.  At intervals after each transfu- 
sion, the clotting time and the rate of prothrombin utilization were determined. 
TABLE VI 
E.~ect o/Addition of Normal Blood or Plasma on Clotting Time and Prottwombin Utilization of 
Hemophilic Blood or Plasma 
Test 
No.  Hemophilic sample 
Whole blood 
Whole blood 
Whole blood 
Platelet-poor 
plasma 
Platelet-poor 
plasma 
Platelet-poor 
plasma 
Platelet-poor 
plasma 
Material added 
Whole blood 
Platelet-rich 
plasmas 
Platelet-poor 
plasma§ 
Whole blood 
Platelet-rich 
plasmas 
Platelet-poor 
plasma§ 
Saline 
Clott 
time 
recalci 
mixtl 
miM 
4i 
s 
3! 
8 
10 
> 120 
> 120 
Residual prothrombin content* 
(per ¢snt of original plasma) 
Time after recalcification 
120 mln.  30 rain. 
<10 
<10 
<10 
39 
51 
100 
100 
50  rain. 
<10 
<10 
<10 
32 
100 
100 
<10 
<10 
<10 
<10 
8 
100 
100 
* All blood and plasma samples were obtained by the silicone technique using 3.2 per cent 
sodium citrate as the anticoagulant.  Volumes  were adjusted in each test so that the mixtures 
contained the equivalent of 10 parts native hemophilic plasma and  1 part native normal 
plasma or saline.  For determination of clotting times and residual prothrombin content (18), 
the mixtures, in plain glassware, were recaicified with optimal amounts of 1.2 per cent CaC12. 
S Contained approximately 150,000 platelets per c.mm. 
§ Contained less than 300 platelets per c.mm. 
By comparison with  pretransfusion values, any improvement in  the  clotting 
process resulting from the transfusion was readily detected. 
Transfusions  with Normal  Blood  and Plasma.--In  one group of ten experi- 
ments,  freshly prepared citrated whole blood or plasma was used.  Both  of 
these preparations promptly corrected the clotting defect.  The dotting time 
immediately after transfusion was reduced to the range 5½ to 9½ minutes, and 
the prothrombin disappeared from shed blood at a nearly normal rate.  Fig. 1 
shows the course of prothrombin conversion in one experiment, typical of the 
group.  The  corrective effect was  independent  of  the  amount  of plasma  or 
blood used in different experiments; from 2.3  to 4.7  ml. citrated plasma or its GRAHAM', BUCKWALTER, HARTLEY,  AND BRINKHOUS  107 
equivalent of whole blood were given per kilo of body weight.  The maximum 
effect was noted in the first blood sample collected a few minutes after transfu- 
sion.  Even  at  that  time,  prothrombin  utilization  was  somewhat  less  rapid 
than  in  normal blood.  Thereafter  the  course  of  clotting  was  progressively 
retarded.  Pretransfusion  values  were reached  in  4  to  7  days. 
Three experiments similar to those described above were done except that 
the normal blood or plasma was aged for 24 hours at 28°C. prior to transfusion. 
The results of one experiment are given in Fig. 2.  The aged preparations ap- 
pear to be less potent than those freshly prepared.  There was less reduction 
IOC 
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• 144  HRS. 
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40  60  80  I00  120 
TIME AFTER BLOOD COLLECTION (MINS.) 
Fio. 1.  A chart showing the effect of a fresh normal citrated plasma transfusion on pro- 
thrombin utilization in a hemophilic dog.  The dose of plasma was 2.7 ml. per kilo of body 
weight.  The solid lines indicate the prothrombin conversion rate at intervals after transfu- 
sion.  The interval is indicated on each curve.  The broken line indicates the conversion 
rate of whole blood of the donor animal. 
in the clotting times following transfusion with these preparations.  The short- 
est clotting times after transfusion ranged from 8  to 13  minutes.  Similarly, 
there was less acceleration in the rate of prothrombin utilization.  These results 
indicate that the corrective principle in normal plasma is only partially stable 
for 1 day at room temperature. 
Transfusions  with Hemophilic Blood and Plasma.--Transfusions  with fresh 
hemophilic preparations were tested in two experiments.  They had no effect 
on the  clotting anomaly.  After transfusion,  the clotting  times and the pro- 
thrombin utilization curves were unchanged from the pretransfusion values. 
In  human  hemophilia,  citrated  whole  blood,  aged  for  24  hours  and  then 
recalcified, has a normal clotting time and a normal prothrombin consumption 
rate  (18).  Hemophilic plasma largely freed of its formed elements, does not 108  CANINE HEMOPHILIA 
exhibit this phenomenon.  It has been postulated  that  transfusions  with nor- 
many  clotting aged whole hemophilic blood would  correct the clotting defect, 
just as normal blood does.  This hypothesis was tested in three experiments on 
our animals.  Two of these experiments are described. 
In one experiment, citrated whole blood, obtained from bleeder dog 8,  was aged for 24 
hours at 28°C.  On recalcification, its clotting time was 3½ minutes.  Sixty ml. of this blood 
(approximately 3.7  ml. per kilo) was transfused  back  to the donor.  This autotransfusion 
caused no change in the clotting defect in the subsequent 48 hours.  At the end of this time 
a transfusion of 60 ml. of normal blood caused a prompt improvement in clotting, similar to 
that seen in Fig. 1. 
Ioo  120 HRS. 
2E 
~  ~o 
48 HRS 
24 HRS 
•  •  15 MINS. 
I  I  I  I  I  I  I  I  I  I  I  I 
20  40  60  80  I00  120 
TIME AFTER BLOOD COLLECTION  (MINS.) 
FIG. 2.  A chart showing the effect of an aged normal citrated plasma transfusion on pro- 
thrombin utilization in a hemophilic dog.  The dose of plasma was 2.8 ml. per kilo of body 
weight.  The lines show the prothrombin conversion rate after transfusion,  at intervals as 
indicated on the chart. 
In another  experiment,  aged citrated whole blood, obtained  from bleeder dog 6,  had  a 
clotting time of 2½ minutes.  The blood  (100 ml. or 5.6 ml. per kilo of body weight) was 
transfused  into another  bleeder animal,  dog 2.  This transfusion  was ineffective. 
Transfusions  with Normal  and HemopMlic Sera.--Normal  and  hemophilic 
sera were used for transfusions in eight experiments.  Neither of these prepara- 
tions  was  effective. 
In one experiment, fresh serum was obtained from normal dog blood.  Within 60 minutes 
after collection of the blood the serum was transfused into bleeder dog 1 (4.4  ml. per kilo 
of body weight).  No change in clotting time or in the rate of prothrombin utilization occurred 
in the recipient.  In a similar experiment, the normal serum was aged for 24 hours at 28°C. 
before transfusion.  It likewise was ineffective.  In a  third  experiment,  hemophilic serum 
was obtained from whole hemophilic blood which had  stood at room temperature  for 24 
hours.  Sixty ml. of the serum was transfused back into dog 6 (2.4 ml. per kilo of body weight). 
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In summary, only normal whole blood and plasma transfusions had a cor- 
rective effect on the delayed clotting in the bleeder dogs. 
DISCUSSION 
The foregoing observations  on canine  hemophilia  indicate that it is  very 
similar to human hemophilia.  The sex-linked inheritance (2), the course of the 
malady, the type of clotting defect,  and the beneficial effects of blood  trans- 
fusions  are very similar,  if not  identical,  in the  two diseases.  The canine 
disease differs from the human disease mainly in the higher  mortality early 
in life, and in the prolonged bleeding from small ear incisions.  One can only 
speculate  whether the higher mortality in untreated bleeder pups is due to a 
more severe clotting defect, or whether it is related to a higher incidence of 
serious  accidents  and infections  in these dogs.  Comparison  of our data on 
prothrombin utilization, and on the amount of thromboplastin required to cause 
a normal clotting rate, with similar data in human hemophilia  (18) does not 
reveal any difference in the severity of the clotting defect.  Perhaps the severe 
bleeding  from ear incisions is due to the character of the tissue at the site 
of puncture, since bleeding stopped promptly from mucous membrane incisions. 
Minimal thromboplastin liberation and inadequate capillary contraction in the 
dense cartilaginous tissues of the ear may  be responsible.  It has been observed 
that the bleeding  time may be prolonged  in human hemophilia,  particularly 
if the puncture is more  than 2 to 3 mm. in depth. 
Further testing of the inheritance of the canine disease is now possible, since 
bleeder animals have been reared to maturity.  The mating of bleeder males 
with females heterozygous for hemophilia will be of particular interest.  This 
union should determine whether the homozygous female can actually occur, or 
whether the genic combination hh is lethal, as has often been suggested. 
The nature of the clotting anomaly in hemophilia  has been the subject of 
much study.  The older views are discussed in a  comprehensive monograph 
by Fonio (19).  Recent studies point to an impaired mobilization of thrombo- 
plastin  which  prevents  conversion  of adequate amounts of prothrombin  to 
thrombin.  As a result, fibrin  formation is slow and incomplete.  Thrombo- 
plastic tissue extracts, added in small quantities to hemophilic blood, promptly 
increase prothrombin utilization and thrombin formation.  Under these cir- 
cumstances,  the hemophilic blood clots promptly.  Normal plasma,  added to 
hemophilic blood, accomplishes within limits the same result.  However,  the 
plasma does not furnish preformed  thromboplastin.  It is seen in Table VI 
that its corrective  action is dependent upon the presence of platelets.  Thus 
it appears  that normally thromboplastin becomes available  in shed blood  as 
a result of the interaction of platelets and the corrective antihemophilic principle 
in plasma.  The exact nature of the platelet-plasma reaction is in doubt.  One 
of us has suggested that the plasma factor is a thrombocytolysin, and that in 110  CANINE IIEMOPIilLIA 
the presence of a wettable surface and Ca  -~, it lyses platelets, thus liberating 
thromboplastin (5).  Alternate explanations for this reaction have been given 
by Macfarlane (20) and by Quick (21).  Regardless of the nature of the reac- 
tion, the data in Table VI would indicate that the mechanism by which ade- 
quate thromboplastin is mobilized may fail,  either because of a  deficiency of 
the antihemophilic factor, or from lack of a  sufficient number of platelets. 
The experiments with aged hemophilic  blood are pertinent to the discussion 
of the clotting anomaly.  On aging,  the blood develops normal clotting prop- 
erties, due apparently to release of thromboplastin from platelets and perhaps 
other formed elements.  Although  the clotting time of the hemophilic  blood 
is the same as fresh normal blood, similarly  treated except for the aging,  the 
blood is not effective in vivo.  These results would indicate that thromboplastin 
as such is not responsible for the effectiveness of normal transfusions.  Rather 
they suggest the need of thromboplastin mobilization at the time the blood is 
shed.  Also,  these experiments indicate that  there is available in hemophilic 
blood a source of thromboplastin, but that it is very slowly mobilized.  These 
findings  lend no support to the hypothesis recently proposed by Quick (21) 
that in hemophilic  blood almost no  thromboplastin is  available from  either 
the plasma or the platelets. 
The failure of normal serum transfusions to correct the dotting defect of the 
hemophilic  blood appears to be significant.  It would indicate that during the 
clotting of normal blood the principle responsible  for the corrective action in 
hemophilia disappears.  This suggests that normally the plasma principle plays 
a fundamental r61e in the initiation of the dotting process,  and that it is con- 
sumed in  the process of clotting. 
su~m~Y 
A study was made of the clotting defect and the course of the malady in a 
group of male dogs with an inherited, sex-linked bleeding disease.  The clotting 
defect is characterized by a prolonged dotting time and a delayed prothrombin 
utilization,  and  is  corrected by the  addition  either  of thromboplastin  or of 
normal plasma.  A plasma protein fraction, fraction I, also corrects the defect. 
The defect appears to be due to a deficiency of a plasma factor, which normally, 
in  the presence of platelets,  makes thromboplastin  available in  shed blood. 
The clotting anomaly appears to be identical with that found in human hemo- 
philia. 
The  hemostatic  defect is  characterized  by repeated hemorrhages,  usually 
without obvious relationship to trauma.  Hemarthroses occur frequently and 
may result in permanent  joint deformity.  The animals  usually die early in 
life from massive hemorrhage. 
Transfusions with normal blood or plasma correct the clotting defect and 
readily control the hemorrhagic phenomena.  By the use of transfusions, these 
dogs have been reared to maturity. GRAIIAM,  BUCKWALTER, HARTLEY~ AND BRI~OUS  111 
We are indebted to Dr. Walter H. Seegers, Wayne University,  for the purified  plasma Ac 
globulin and to the American Red Cross for the human fraction I. 
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